Pfizer buys sickle cell drugmaker Global Blood for $5.4B
BioNTech expects Omicron-adapted vaccine deliveries as soon as October
Eli Lilly says Indiana's abortion ban will force it to hire more outside the state
AI innovation among clinical trial companies dropped in the past quarter
*please scroll down for all the latest news*
